Evidence map›Paper›PMID 40220998›Full record

ArticleThe Journal of biological chemistry2025

Mechanism of glutathionylation of the active site thiols of peroxiredoxin 2.

Alexander V Peskin, Flavia C Meotti, Nicholas J Magon, Luiz F de Souza, Armindo Salvador, Christine C Winterbourn

Erratum issuedAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Alexander V PeskinMātai Hāora - Centre for Redox Biology and Medicine, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Flavia C MeottiDepartment of Biochemistry, Chemistry Institute, University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
Nicholas J MagonMātai Hāora - Centre for Redox Biology and Medicine, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Luiz F de SouzaDepartment of Biochemistry, Chemistry Institute, University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
Armindo SalvadorCNC-UC - Centre for Neuroscience Cell Biology, University of Coimbra, Coimbra, Portugal; CiBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal; Coimbra Chemistry Center - Institute of Molecular Sciences (CQC-IMS), University of Coimbra, Coimbra, Portugal; Institute for Interdisciplinary Research, University of Coimbra, Coimbra, Portugal. Electronic address: salvador@cnc.uc.pt.
Christine C WinterbournMātai Hāora - Centre for Redox Biology and Medicine, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. Electronic address: christine.winterbourn@otago.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxiredoxin 2 (Prdx2) undergoes ready glutathionylation, and glutaredoxin-catalyzed deglutathionylation provides an alternative mechanism to thioredoxin/thioredoxin reductase for recycling the reduced protein (Peskin et al. JBC 216, 3053, 2016). To elucidate the mechanism of glutathionylation, we have carried out kinetic studies using stopped flow and SDS PAGE plus product analysis by mass spectrometry. Kinetic modeling shows a mechanism in which exchange of Prdx2 disulfide with physiological concentrations of GSH occurs over seconds to minutes, initially at one active site to produce glutathionylated dimers linked by one disulfide. Exchange with GSH yields glutathionylation at both the peroxidatic (C

Indexed as

GlutathionePeroxiredoxinsSulfhydryl CompoundsCatalytic DomainCysteineDisulfidesGlutaredoxinsHumansKineticsOxidation-ReductionCysteineDisulfidesGlutaredoxinsGlutathionePeroxiredoxinsPRDX2 protein, humanSulfhydryl Compoundsantioxidantglutathionylationkinetic modelingperoxiredoxinredox signalingthiol

Identifiers

PMID40220998
PMCPMC12137162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.